Imprivata Inc. (IMPR) Given Average Recommendation of “Hold” by Brokerages
Shares of Imprivata Inc. (NYSE:IMPR) have been assigned an average rating of “Hold” from the ten ratings firms that are currently covering the company. Seven investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The average twelve-month price target among brokers that have covered the stock in the last year is $16.00.
IMPR has been the topic of a number of recent research reports. Zacks Investment Research upgraded Imprivata from a “hold” rating to a “buy” rating and set a $16.00 target price on the stock in a research note on Wednesday, June 29th. Stifel Nicolaus downgraded Imprivata from a “buy” rating to a “hold” rating in a research note on Wednesday, July 13th. Wells Fargo & Co. downgraded Imprivata from an “outperform” rating to a “market perform” rating in a research note on Tuesday, August 2nd. Leerink Swann downgraded Imprivata from an “outperform” rating to a “market perform” rating in a research note on Thursday, July 14th. Finally, Piper Jaffray Cos. downgraded Imprivata from an “overweight” rating to a “neutral” rating in a research note on Wednesday, July 13th.
Several institutional investors have recently bought and sold shares of IMPR. Schwab Charles Investment Management Inc. boosted its position in Imprivata by 57.0% in the second quarter. Schwab Charles Investment Management Inc. now owns 24,800 shares of the company’s stock valued at $348,000 after buying an additional 9,000 shares in the last quarter. Metropolitan Life Insurance Co. NY acquired a new position in Imprivata during the second quarter valued at $185,000. Highbridge Capital Management LLC acquired a new position in Imprivata during the second quarter valued at $334,000. Capital World Investors acquired a new position in Imprivata during the second quarter valued at $5,336,000. Finally, Menta Capital LLC boosted its position in Imprivata by 39.5% in the second quarter. Menta Capital LLC now owns 36,973 shares of the company’s stock valued at $518,000 after buying an additional 10,461 shares in the last quarter. 59.34% of the stock is owned by institutional investors and hedge funds.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at https://www.americanbankingnews.com/2016/10/13/imprivata-inc-impr-given-average-recommendation-of-hold-by-brokerages.html
Imprivata (NYSE:IMPR) remained flat at $19.26 during trading on Thursday. Imprivata has a 12-month low of $9.00 and a 12-month high of $19.28. The firm’s 50 day moving average is $19.24 and its 200-day moving average is $15.96.
Imprivata (NYSE:IMPR) last issued its earnings results on Tuesday, August 2nd. The company reported ($0.14) EPS for the quarter, beating analysts’ consensus estimates of ($0.19) by $0.05. Imprivata had a negative return on equity of 49.06% and a negative net margin of 18.17%. Analysts predict that Imprivata will post ($0.44) EPS for the current fiscal year.
Imprivata Company Profile
Imprivata, Inc is engaged in providing healthcare information technology (IT) solutions. The Company’s IT security and identity platform provides authentication management, fast access to patient information, secure communications and positive patient identification products to the healthcare industry.
Receive News & Ratings for Imprivata Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imprivata Inc. and related companies with MarketBeat.com's FREE daily email newsletter.